This is interesting since the transient receptor potential vanilloid 1 (TRPV1), which is involved in visceral pain signaling, is up-regulated in IBS patients where it stimulates increased release of somatostatin and SP [52]. This evidence concerns the gene TFF2 and irritable bowel syndrome.